KOS-1584: Interim Phase I data

Interim data from an ongoing, open-label Phase I trial in 37 patients showed

Read the full 131 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE